Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ppi-668
1. Ravidasvir [usan]
2. 1242087-93-9
3. Ppi-668 Free Base
4. Al3g001bi8
5. Bi 238630
6. Bi-238630
7. Carbamic Acid, N-((1s)-1-(((2s)-2-(5-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-1h-benzimidazol-6-yl)-2-naphthalenyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)-, Methyl Ester
8. Methyl N-((1s)-1-(((2s)-2-(5-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3- Methylbutanoyl)pyrrolidin-2-yl)-1h-imidazol-4-yl)naphthalen-2-yl)-1h-benzimidazol-2-yl)pyrrolidin-1-yl)carbonyl)-2-methylpropyl)carbamate
9. Methyl N-[(2s)-1-[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-3h-benzimidazol-5-yl]naphthalen-2-yl]-1h-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
10. Carbamic Acid, N-[(1s)-1-[[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1h-benzimidazol-6-yl]-2-naphthalenyl]-1h-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, Methyl Ester
11. Unii-al3g001bi8
12. Ravidasvir Free Base
13. Bl-238630
14. Ravidasvir [inn]
15. Ravidasvir [who-dd]
16. Schembl7603463
17. Chembl3121849
18. Schembl12075676
19. Bdbm243443
20. Dtxsid401335997
21. Us9427428, 3
22. Q27273972
23. Methyl ((1s)-1-(((2s)-2-(4-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-benzimidazol-5-yl)-2-naphthyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate
24. Methyl N-[(1s)-1-[[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1h-benzimidazol-6-yl]-2-naphthalenyl]-1h-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate
25. Methyl((1s)-1-(((2s)-2-(4-(6-(2-((2s)-1-((2s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1h-benzimidazol-5-yl)-2-naphthyl)-1h-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate
26. Methyl((s)-1-((s)-2-(5-(6-(2((s)-1-((methoxycarbonyl)-l-valyl)pyrrolidin-2-yl)-1h-imidazol-4-yl)naphthalen-2-yl)-1h-benzo[d]imidazol-2-yl) Pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
27. Methyln-[(1s)-1-[[(2s)-2-[5-[6-[2-[(2s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1h-benzimidazol-6-yl]-2-naphthalenyl]-1h-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate
Molecular Weight | 762.9 g/mol |
---|---|
Molecular Formula | C42H50N8O6 |
XLogP3 | 6.1 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 12 |
Exact Mass | 762.38533134 g/mol |
Monoisotopic Mass | 762.38533134 g/mol |
Topological Polar Surface Area | 175 Ų |
Heavy Atom Count | 56 |
Formal Charge | 0 |
Complexity | 1400 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A Ravidasvir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ravidasvir, including repackagers and relabelers. The FDA regulates Ravidasvir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ravidasvir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ravidasvir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ravidasvir supplier is an individual or a company that provides Ravidasvir active pharmaceutical ingredient (API) or Ravidasvir finished formulations upon request. The Ravidasvir suppliers may include Ravidasvir API manufacturers, exporters, distributors and traders.
click here to find a list of Ravidasvir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ravidasvir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ravidasvir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ravidasvir GMP manufacturer or Ravidasvir GMP API supplier for your needs.
A Ravidasvir CoA (Certificate of Analysis) is a formal document that attests to Ravidasvir's compliance with Ravidasvir specifications and serves as a tool for batch-level quality control.
Ravidasvir CoA mostly includes findings from lab analyses of a specific batch. For each Ravidasvir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ravidasvir may be tested according to a variety of international standards, such as European Pharmacopoeia (Ravidasvir EP), Ravidasvir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ravidasvir USP).
LOOKING FOR A SUPPLIER?